From GlobeNewswire:

SI-BONE, Inc. will report financial results for Q4 and full year ending December 31, 2023 on February 26, 2024. Investors can join the conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Register for the webcast at the company’s website and listen to live audio. The webcast will be available for replay for 90 days after the event.

SI-BONE is a global leader in surgical treatment of musculoskeletal disorders offering technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. They have supported over 3,600 surgeons in performing over 95,000 sacropelvic procedures with a unique body of clinical evidence to support their technologies, including two randomized controlled trials and over 125 peer-reviewed publications.

Visit www.si-bone.com for more information about the company or the products, including risks and benefits. SI-BONE offers surgical solutions for musculoskeletal disorders and has registered trademarks for their products, including iFuse Bedrock Granite, iFuse-TORQ, and SI-BONE. For investor inquiries, contact Saqib Iqbal at [email protected].



Read more: SI-BONE To Report Fourth-Quarter and Full-Year 2023